Auricular Stimulation for Functional Dyspepsia With Insomnia: Efficacy and Mechanisms

Recruiting now · Not applicable

Conditions studied: Functional Dyspepsia, Insomnia, Brain and Nervous System

In brief

Functional dyspepsia (FD) is a chronic disorder of gut-brain interaction characterized by bothersome upper abdominal symptoms arising from the gastroduodenal region. Diagnosis is made after clinical evaluation has excluded structural disease that could explain symptoms (e.g., upper gastrointestinal endoscopy). According to Rome IV criteria, FD is categorized into postprandial distress syndrome (PDS) and epigastric pain syndrome (EPS), with symptom overlap commonly observed. FD is prevalent worldwide and is associated with substantial impairment in health-related quality of life and a significant socioeconomic burden. Sleep disturbance, anxiety, and depression are frequent in FD and are associated with symptom severity and recurrence. Current management-such as prokinetic agents, acid-suppressive therapy, and psychotropic medications when indicated-can be limited by variable efficacy, adverse effects, and concerns regarding long-term use. The pathophysiology of FD is multifactorial and incompletely understood; increasing evidence highlights dysregulation of the brain-gut axis and autonomic nervous system function (12,13). Auricular vagus nerve-related stimulation may influence brainstem neurotransmission, gastric tone/motility, and mood (14), suggesting a potentially safe, non-pharmacological approach for FD with comorbid sleep problems. However, the mechanistic links among autonomic regulation, gut microbiota/short-chain fatty acids, and FD remain uncertain. This study aims to evaluate the clinical efficacy and safety of auricular acupoint stimulation in FD patients with sleep disorders and to explore underlying mechanisms using brain-function assessments together with autonomic and gastrointestinal-related measures.

Key facts

Study ID: NCT07442734
Run by: The First Affiliated Hospital of Zhejiang Chinese Medical University
People needed: 176
Starts: 2025-10-30
Expected to finish: 2026-10-01
Last updated by the study team: 2026-03-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Meet the diagnostic criteria for functional dyspepsia and sleep disorders (25,26)
Pittsburgh Sleep Quality Index score ≥7
Right-handed, aged 18 years or above
Have not taken the following medications for at least 2 weeks prior to enrollment: antibiotics (oral, intramuscular, or intravenous), microbiota-related products (probiotics, prebiotics, and synbiotics, etc.), or any drugs affecting gastrointestinal flora, any drugs or supplements that improve sleep quality or suppress neural activity in the brain, medications related to functional dyspepsia treatment, or other related therapies
Agree to voluntarily participate in this study and sign the informed consent form

You may not qualify if…

Secondary insomnia caused by drugs or other diseases
Comorbidity with other psychiatric disorders, or severe heart, liver, kidney, or other systemic diseases
Previously received this treatment method or participated in other clinical trials within the past 6 months
Presence of contraindications to auricular therapy, such as allergy to skin preparation or damage at the auricular application site
Pregnant or breastfeeding women
History of cranial organic lesions, cranial surgery, or severe trauma

Where it is running

First Affiliated Hospital of Zhejiang Chinese Medical University — Hangzhou, Zhejiang, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.